These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15611130)

  • 41. The TWEAK-Fn14 system as a potential drug target.
    Wajant H
    Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated fibroblast growth factor-inducible 14 expression promotes gastric cancer growth via nuclear factor-κB and is associated with poor patient outcome.
    Kwon OH; Park SJ; Kang TW; Kim M; Kim JH; Noh SM; Song KS; Yoo HS; Wang Y; Pocalyko D; Paik SG; Kim YH; Kim SY; Kim YS
    Cancer Lett; 2012 Jan; 314(1):73-81. PubMed ID: 21993017
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells.
    Tirnitz-Parker JE; Viebahn CS; Jakubowski A; Klopcic BR; Olynyk JK; Yeoh GC; Knight B
    Hepatology; 2010 Jul; 52(1):291-302. PubMed ID: 20578156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration.
    Potrovita I; Zhang W; Burkly L; Hahm K; Lincecum J; Wang MZ; Maurer MH; Rossner M; Schneider A; Schwaninger M
    J Neurosci; 2004 Sep; 24(38):8237-44. PubMed ID: 15385607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion.
    Armstrong CL; Galisteo R; Brown SA; Winkles JA
    Oncotarget; 2016 Dec; 7(49):81474-81492. PubMed ID: 27821799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.
    Gurunathan S; Winkles JA; Ghosh S; Hayden MS
    J Biol Chem; 2014 May; 289(19):12976-88. PubMed ID: 24652288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.
    Nakayama M; Ishidoh K; Kojima Y; Harada N; Kominami E; Okumura K; Yagita H
    J Immunol; 2003 Jan; 170(1):341-8. PubMed ID: 12496418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation.
    Cheng H; Xu M; Liu X; Zou X; Zhan N; Xia Y
    Exp Dermatol; 2016 Jan; 25(1):32-7. PubMed ID: 26264384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
    Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J
    Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.
    Wiley SR; Winkles JA
    Cytokine Growth Factor Rev; 2003; 14(3-4):241-9. PubMed ID: 12787562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha.
    Bui NT; Livolsi A; Peyron JF; Prehn JH
    J Cell Biol; 2001 Feb; 152(4):753-64. PubMed ID: 11266466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.
    Wang D; Fung JN; Tuo Y; Hu L; Chen C
    Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
    Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
    Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TWEAK/Fn14 signaling in tumors.
    Hu G; Zeng W; Xia Y
    Tumour Biol; 2017 Jun; 39(6):1010428317714624. PubMed ID: 28639899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
    Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
    Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation.
    Polavarapu R; Gongora MC; Winkles JA; Yepes M
    J Neurosci; 2005 Nov; 25(44):10094-100. PubMed ID: 16267216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.
    Huang M; Narita S; Tsuchiya N; Ma Z; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T
    Carcinogenesis; 2011 Nov; 32(11):1589-96. PubMed ID: 21828059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules.
    Brown SA; Hanscom HN; Vu H; Brew SA; Winkles JA
    Biochem J; 2006 Jul; 397(2):297-304. PubMed ID: 16526941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein.
    Dogra C; Changotra H; Mohan S; Kumar A
    J Biol Chem; 2006 Apr; 281(15):10327-36. PubMed ID: 16461349
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.
    Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR
    J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.